Benison C. Lau
Pediatric Hematology Oncology
4401 Penn Avenue, Floor 3
Pittsburgh, PA 15224
Pittsburgh, PA 15224
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
Tumor extracellular vesicle RNA profiling predicts treatment response in pediatric diffuse midline glioma.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2026
Early increase in apparent diffusion coefficient predicts favorable response to Dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma.
Journal: Neuro-oncology
Published: December 18, 2025
Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma.
Journal: Cancers
Published: January 25, 2025
GABA production induced by imipridones is a targetable and imageable metabolic alteration in diffuse midline gliomas.
Journal: bioRxiv : the preprint server for biology
Published: June 25, 2024
Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.
Journal: Cell reports. Medicine
Published: November 14, 2023
T1-weighted MRI as a substitute to CT for refocusing planning in MR-guided focused ultrasound.
Journal: Physics in medicine and biology
Published: June 10, 2014
Last Updated: 09/26/2026